Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
DNA-pas belooft minder bijwerkingen, betere patiëntenzorg en lagere kosten
apr 2023